{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:42:16Z","timestamp":1793374936843,"version":"4.5.0"},"reference-count":21,"publisher":"Jaypee Brothers Medical Publishing","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.59556\/japi.74.1296","type":"journal-article","created":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:08:06Z","timestamp":1771823286000},"page":"22-26","source":"Crossref","is-referenced-by-count":2,"title":["Mineralocorticoid Receptor Antagonists: The Pillar Drug in Heart Failure"],"prefix":"10.59556","volume":"74","author":[{"given":"Rishi","family":"Sethi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajat","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram A","family":"Raj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaya","family":"PV","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Thakran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev K","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanta","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K Murali M","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemshankar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Febin","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amarnath","family":"Sugumaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthilnathan","family":"Mohanasundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2914","reference":[{"issue":"(2):","key":"key20260223050803_B1","doi-asserted-by":"crossref","first-page":"152\u2013","DOI":"10.1093\/eurheartj\/ehaa736","article-title":"Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine.","volume":"42","author":"Agarwal","year":"2021;","journal-title":"Eur Heart J"},{"issue":"(10458):","key":"key20260223050803_B2","doi-asserted-by":"crossref","first-page":"1119\u2013","DOI":"10.1016\/S0140-6736(24)01733-1","article-title":"Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis.","volume":"404","author":"Jhund","year":"2024;","journal-title":"Lancet"},{"issue":"(9):","key":"key20260223050803_B3","first-page":"e45241.","article-title":"Impact of mineralocorticoid receptor antagonists in the treatment of heart failure: targeting the heart failure cascade.","volume":"15","author":"Jadhav","year":"2023;","journal-title":"Cureus"},{"issue":"(1):","key":"key20260223050803_B4","doi-asserted-by":"crossref","first-page":"4.","DOI":"10.1007\/s11892-019-1123-8","article-title":"Mineralocorticoid antagonism and diabetic kidney disease.","volume":"19","author":"Lytvyn","year":"2019;","journal-title":"Curr Diab Rep"},{"issue":"(10):","key":"key20260223050803_B5","doi-asserted-by":"crossref","first-page":"709\u2013","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.","volume":"341","author":"Pitt","year":"1999;","journal-title":"N Engl J Med"},{"key":"key20260223050803_B6","first-page":"6\u2013","article-title":"Mineralocorticoid receptor antagonist in heart failure: past, present and future perspectives.","volume":"3:","author":"Vizzardi","year":"2014;","journal-title":"Int J Cardiol Heart Vessel"},{"issue":"(14):","key":"key20260223050803_B7","doi-asserted-by":"crossref","first-page":"1309\u2013","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.","volume":"348","author":"Pitt","year":"2003;","journal-title":"N Engl J Med"},{"issue":"(1):","key":"key20260223050803_B8","doi-asserted-by":"crossref","first-page":"11\u2013","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms.","volume":"364","author":"Zannad","year":"2011;","journal-title":"N Engl J Med"},{"issue":"(15):","key":"key20260223050803_B9","doi-asserted-by":"crossref","first-page":"1383\u2013","DOI":"10.1056\/NEJMoa1313731","article-title":"Spironolactone for heart failure with preserved ejection fraction.","volume":"370","author":"Pitt","year":"2014;","journal-title":"N Engl J Med"},{"issue":"(16):","key":"key20260223050803_B10","doi-asserted-by":"crossref","first-page":"1475\u2013","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction.","volume":"391","author":"Solomon","year":"2024;","journal-title":"N Engl J Med"},{"issue":"(18):","key":"key20260223050803_B11","first-page":"e895\u2013","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines.","volume":"145","author":"Heidenreich","year":"2022;","journal-title":"Circulation"},{"issue":"(5):","key":"key20260223050803_B12","doi-asserted-by":"crossref","first-page":"455\u2013","DOI":"10.1093\/eurheartj\/ehv464","article-title":"Influence of ejection fraction on outcomes and efficacy of spironolactone in patients with heart failure with preserved ejection fraction.","volume":"37","author":"Solomon","year":"2016;","journal-title":"Eur Heart J"},{"issue":"(1):","key":"key20260223050803_B13","first-page":"4\u2013","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC.","volume":"24","author":"McDonagh","year":"2022;","journal-title":"Eur J Heart Fail"},{"issue":"(2):","key":"key20260223050803_B14","doi-asserted-by":"crossref","first-page":"106\u2013","DOI":"10.1016\/j.jacc.2024.09.004","article-title":"Finerenone in patients with a recent worsening heart failure event: the FINEARTS-HF trial.","volume":"85","author":"Desai","year":"2025;","journal-title":"J Am Coll Cardiol"},{"issue":"(37):","key":"key20260223050803_B15","doi-asserted-by":"crossref","first-page":"3627\u2013","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC.","volume":"44","author":"McDonagh","year":"2023;","journal-title":"Eur Heart J"},{"issue":"(Suppl 1):","key":"key20260223050803_B16","doi-asserted-by":"crossref","first-page":"S1\u2013","DOI":"10.1016\/j.ihj.2018.05.003","article-title":"CSI position statement on management of heart failure in India.","volume":"70","author":"Guha","year":"2018;","journal-title":"Indian Heart J"},{"issue":"(1):","key":"key20260223050803_B17","doi-asserted-by":"crossref","first-page":"53\u2013","DOI":"10.1023\/A:1015371616135","article-title":"Economic evaluation of the randomized aldactone evaluation study (RALES): treatment of patients with severe heart failure.","volume":"16","author":"Glick","year":"2002;","journal-title":"Cardiovasc Drugs Ther"},{"issue":"(9):","key":"key20260223050803_B18","doi-asserted-by":"crossref","first-page":"1106\u2013","DOI":"10.1161\/01.CIR.0000157146.86758.BC","article-title":"Cost-effectiveness of eplerenone compared with placebo in patients with myocardial infarction complicated by left ventricular dysfunction and heart failure.","volume":"111","author":"Weintraub","year":"2005;","journal-title":"Circulation"},{"issue":"(1):","key":"key20260223050803_B19","doi-asserted-by":"crossref","first-page":"55\u2013","DOI":"10.2165\/11319940-000000000-00000","article-title":"Cost effectiveness of eplerenone in patients with heart failure after acute myocardial infarction who were taking both ACE inhibitors and beta-blockers: subanalysis of the EPHESUS.","volume":"10","author":"Zhang","year":"2010;","journal-title":"Am J Cardiovasc Drugs"},{"issue":"(18):","key":"key20260223050803_B20","doi-asserted-by":"crossref","first-page":"1835\u2013","DOI":"10.1016\/j.jacc.2023.03.393","article-title":"2023 ACC expert consensus decision pathway on management of heart failure with preserved ejection fraction.","volume":"81","author":"Kittleson","year":"2023;","journal-title":"JACC"},{"issue":"(2):","key":"key20260223050803_B21","doi-asserted-by":"crossref","first-page":"243\u2013","DOI":"10.1007\/s40119-024-00367-4","article-title":"Management of heart failure in a resource-limited setting: expert opinion from India.","volume":"13","author":"Jain","year":"2024;","journal-title":"Cardiol Ther"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T05:08:09Z","timestamp":1771823289000},"score":1,"resource":{"primary":{"URL":"https:\/\/japi.org\/article\/japi-74-1-s1-22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.59556\/japi.74.1296"],"URL":"https:\/\/doi.org\/10.59556\/japi.74.1296","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}